Literature DB >> 28609556

Prevention of livedoid vasculopathy recurrence by prolonged administration of rivaroxaban.

C Drerup1, T Goerge1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28609556     DOI： 10.1111/jdv.14404

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  2 in total

Review 1.  Livedoid vasculopathy: A multidisciplinary clinical approach to diagnosis and management.

Authors:  Asli Bilgic; Salih Ozcobanoglu; Burcin Cansu Bozca; Erkan Alpsoy
Journal:  Int J Womens Dermatol       Date:  2021-09-02

Review 2.  Comparative Efficacy of Rivaroxaban and Immunoglobulin Therapy in the Treatment of Livedoid Vasculopathy: A Systematic Review.

Authors:  Shivana Ramphall; Swarnima Rijal; Vishakh Prakash; Heba Ekladios; Jiya Mulayamkuzhiyil Saju; Naishal Mandal; Nang I Kham; Rabia Shahid; Shaili S Naik; Sathish Venugopal
Journal:  Cureus       Date:  2022-08-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.